Hip Replacement Market Size By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), By Statistics, Trends, Outlook and Forecast 2025 to 2032 (Financial Impact Analysis)

Hip Replacement Market Size

The Hip Replacement Market is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.8% between 2025 and 2032. The market is estimated at USD 6.2 billion in 2025 and is projected to reach USD 8.5 billion by the end of the forecast period in 2032.

Hip Replacement Market introduction

The Hip Replacement Market encompasses a sophisticated array of medical devices and surgical procedures specifically engineered to alleviate chronic pain, restore mobility, and enhance the quality of life for patients suffering from severe hip joint pathologies. These debilitating conditions frequently arise from degenerative diseases such as osteoarthritis, inflammatory conditions like rheumatoid arthritis, ischemic bone death caused by avascular necrosis, or acute traumatic injuries resulting in complex hip fractures. The core therapeutic intervention involves the precise surgical implantation of prosthetic components to replace damaged bone and cartilage within the acetabulum and femoral head, enabling patients to regain essential functional independence and a significantly improved daily existence. This highly specialized segment of orthopedic surgery represents a critical solution for an ever-growing global geriatric population and individuals prematurely affected by severe joint degeneration.

Product offerings within this market are characterized by their modular design, typically comprising a femoral stem, a meticulously crafted femoral head (ball), and an acetabular cup accompanied by a specialized liner. These components are meticulously fabricated from advanced biomaterials, including robust cobalt-chromium alloys, lightweight titanium, high-strength ceramics, and innovative ultra-high molecular weight polyethylene (UHMWPE), particularly its highly cross-linked variants. The selection of these materials is predicated on their exceptional biocompatibility, long-term durability, superior wear resistance, and mechanical integrity, all of which are paramount for ensuring successful long-term implant performance and minimizing revision surgery rates. Major applications of these implants span a spectrum of procedures, including total hip arthroplasty (THA), partial hip arthroplasty (hemiarthroplasty), hip resurfacing, and complex revision surgeries, each tailored to address specific patient anatomies and pathological presentations.

The profound benefits afforded to patients undergoing hip replacement surgery are multifaceted and life-altering, primarily manifesting as substantial relief from persistent pain, comprehensive restoration of normal joint function, a remarkable improvement in the range of motion, and an enhanced capacity to perform daily activities without debilitating discomfort. This collectively leads to a profound elevation in their overall quality of life and independence. Key driving factors propelling the robust growth of this market include the inexorable global demographic shift towards an older population, which inherently increases the prevalence of age-related orthopedic conditions. Additionally, continuous, groundbreaking advancements in implant design, biomaterials science, and sophisticated surgical techniques, alongside a rising global patient awareness regarding effective treatment options for chronic hip pain, synergistically contribute to the sustained expansion and innovation within this vital market landscape.

Hip Replacement Market Executive Summary

The Hip Replacement Market is experiencing robust and sustained growth, primarily fueled by significant demographic shifts and continuous technological innovation across the globe. Prominent business trends within the industry include a strategic drive towards consolidation among leading manufacturers, aiming to enhance market share and optimize operational efficiencies. Concurrently, there is an intensified focus on the development and adoption of minimally invasive surgical techniques, which promise reduced patient recovery times and improved cosmetic outcomes. Furthermore, personalized implant solutions, often facilitated by advanced imaging and manufacturing technologies, are gaining traction as companies strive to offer patient-specific treatments. Manufacturers are significantly increasing their investments in research and development to introduce next-generation materials and designs that not only promise superior longevity but also aim to drastically reduce the incidence of revision surgeries, directly responding to the evolving demands from both patients and orthopedic surgeons for enhanced, durable clinical outcomes. The market is also strategically aligning with value-based care models, compelling companies to prioritize efficacy, safety, and cost-effectiveness across their product portfolios.

Regional trends reveal distinct dynamics within the global Hip Replacement Market. North America and Europe continue to represent mature and dominant markets, characterized by well-established healthcare infrastructures, substantial levels of healthcare expenditure, and a high rate of adoption for the most advanced hip replacement technologies. These regions benefit from extensive research and development investments, fostering continuous innovation. In stark contrast, the Asia Pacific region is rapidly emerging as the fastest-growing market segment, propelled by a confluence of factors including a burgeoning and rapidly aging population, significant increases in healthcare expenditure, and substantial improvements in medical infrastructure and access to advanced care. Latin America, alongside the Middle East and Africa, are also demonstrating considerable potential for growth, driven by rising health awareness, economic development, and an expanding medical tourism sector, although they still grapple with challenges related to healthcare access and affordability in underserved areas. These pronounced geographical variations necessitate highly tailored market entry, expansion, and distribution strategies for all participants in the industry.

Segmentation trends within the Hip Replacement Market highlight evolving preferences and technological advancements. There is an increasing inclination towards ceramic-on-polyethylene and ceramic-on-ceramic bearing surfaces, primarily due to their superior wear characteristics, excellent biocompatibility, and significantly reduced risk of osteolysis compared to older material combinations. While metal-on-polyethylene implants continue to hold a considerable market share, largely owing to their proven track record and cost-effectiveness, the shift towards more advanced materials is evident. Furthermore, the demand for cementless fixation implants is steadily gaining precedence over traditional cemented options, especially among younger, more active patient populations, attributed to their potential for biological bone ingrowth and long-term mechanical stability. Total hip arthroplasty procedures persistently remain the largest and most frequently performed segment within the market. Concurrently, the revision hip replacement segment is experiencing significant growth as the installed base of primary implants reaches their expected lifespan or requires replacement due to wear, infection, or other complications. These segment-specific dynamics are profoundly influencing product development pipelines, marketing strategies, and resource allocation across the entire hip replacement industry.

AI Impact Analysis on Hip Replacement Market

User inquiries surrounding the integration of Artificial Intelligence (AI) into the Hip Replacement Market frequently focus on its transformative potential to significantly elevate surgical precision, enhance patient-specific outcomes, and notably expedite post-operative recovery periods. There is a palpable curiosity regarding how AI-driven tools can render procedures inherently safer, markedly more efficient, and profoundly personalized, moving beyond a one-size-fits-all approach. Concurrently, users voice legitimate concerns encompassing issues of data privacy and security, the intricate ethical considerations surrounding AI-driven medical decision-making, and the perceived potential for advanced technology to either augment or, in some cases, even potentially displace highly specialized human surgical skills. Despite these considerations, there is a strong and widespread expectation that AI will deliver sophisticated diagnostic capabilities, advanced predictive analytics for accurately assessing complication risks, and highly refined tools for both comprehensive pre-operative planning and meticulous intra-operative execution, thereby culminating in a far more streamlined, precise, and ultimately effective treatment pathway for individuals requiring hip replacement surgery.

• AI-driven pre-operative planning leverages advanced imaging and anatomical data to create highly accurate 3D models, enabling precise implant sizing, orientation, and optimal surgical approach tailored to each patient.
• Intra-operative robotic assistance guided by AI algorithms enhances surgical precision, minimizing human error and improving alignment and leg length equality.
• Predictive analytics powered by AI can identify patients at higher risk of post-operative complications or implant failure, enabling proactive intervention.
• AI aids in personalized rehabilitation programs by analyzing patient data to recommend tailored exercises and recovery pathways, potentially accelerating recuperation.
• Machine learning models can analyze vast datasets of surgical outcomes to identify best practices and continuously refine procedural techniques.
• AI-enabled imaging analysis tools provide more detailed and accurate interpretations of X-rays and CT scans, assisting in diagnosis and surgical assessment.
• Automation of routine tasks through AI can free up surgical staff to focus on more complex aspects of patient care, enhancing overall operational efficiency.
• Remote patient monitoring systems integrated with AI can track recovery progress and detect early signs of issues, providing timely alerts to healthcare providers.

DRO & Impact Forces Of Hip Replacement Market

The Hip Replacement Market operates within a complex ecosystem profoundly influenced by a dynamic interplay of drivers, inherent restraints, emerging opportunities, and significant overarching impact forces that collectively determine its growth trajectory and future landscape. A primary and undeniable driver is the burgeoning global geriatric population; as individuals age, they are inherently more susceptible to degenerative joint diseases such as osteoarthritis and rheumatoid arthritis, leading to an escalating demand for effective hip replacement surgeries. Furthermore, an increasing level of awareness among both patients and the general public regarding advanced and highly effective treatment options, coupled with a pervasive societal demand for maintaining an improved quality of life and functional independence well into older age, actively propels individuals to seek definitive surgical interventions. Crucially, continuous and rapid technological advancements in implant biomaterials, innovative implant designs, and sophisticated surgical techniques, including the widespread adoption of minimally invasive approaches and precision robotic-assisted procedures, also contribute substantially to market expansion by consistently enhancing surgical efficacy, improving long-term outcomes, and significantly reducing post-operative recovery times, making the procedure more appealing and accessible to a broader patient demographic.

Despite these powerful drivers, the market is simultaneously constrained by several significant factors that impede its unrestrained expansion. The high financial cost associated with hip replacement procedures, which encompasses not only the specialized implant expenses but also significant surgical fees, hospital stays, and rehabilitation costs, can represent a substantial barrier for many patients, particularly in regions burdened by limited health insurance coverage or inadequately funded public healthcare systems. Furthermore, the industry faces stringent and often lengthy regulatory approval processes for new medical devices and innovative materials, which can significantly delay market entry, stifle rapid innovation, and increase development costs. Additionally, the inherent risk of post-operative complications such as deep joint infection, implant dislocation, periprosthetic fracture, or aseptic loosening, alongside the critical need for highly specialized surgical expertise, advanced infrastructure, and dedicated post-operative care, can limit the accessibility and widespread adoption of hip replacement in certain underserved healthcare settings. A persistent global shortage of adequately trained orthopedic surgeons, particularly in many developing regions, also represents a significant impediment to achieving broader market penetration and equitable access to care.

Nevertheless, the Hip Replacement Market is rich with substantial and compelling opportunities poised to redefine its future. Emerging economies, particularly those in the vast Asia Pacific and rapidly developing Latin American regions, represent considerable untapped potential. This is driven by their rapidly improving healthcare infrastructure, substantial increases in overall healthcare expenditure, and a large, aging patient pool that is increasingly demanding advanced medical solutions. The advent and ongoing refinement of personalized implants, meticulously manufactured through advanced 3D printing technologies and tailored precisely to individual patient anatomies, offer a high-value growth niche, promising optimized fit, improved biomechanics, and potentially superior long-term clinical outcomes. Furthermore, the expansive integration of robotic-assisted surgery and the sophisticated application of artificial intelligence for comprehensive surgical planning and real-time intra-operative guidance present unprecedented avenues for dramatically enhanced precision, standardization of surgical techniques, and ultimately, a reduction in procedural variability. The accelerating trend of performing hip replacements in ambulatory surgical centers (ASCs) points towards increased procedural efficiency, reduced hospital stay durations, and lower overall costs, thereby broadening patient access to elective hip arthroplasty procedures. These innovative opportunities are collectively positioned to fundamentally reshape and significantly expand the future treatment landscape of hip replacement.

Segmentation Analysis

The Hip Replacement Market is extensively segmented across several critical dimensions, providing a granular and insightful breakdown of its underlying market dynamics. These dimensions include product type, the specific materials utilized in implant fabrication, the primary end-user settings, and the types of surgical procedures performed. This comprehensive segmentation is instrumental in revealing distinct market trends, nuanced consumer preferences, varying adoption rates of technological innovations, and the geographical distribution of demand across diverse categories. For medical device manufacturers, healthcare providers, and strategic investors, gaining a thorough understanding of these segments is absolutely crucial. It allows them to accurately identify the most lucrative areas for future innovation, develop effective strategies for market penetration, and strategically allocate resources for sustained growth. The inherent diversity encapsulated within these segments directly reflects the complex medical needs of a global patient population and the evolving approaches to modern hip arthroplasty.

• Product Type: This segment categorizes implants based on the extent of the joint replacement and their intended use.
  • Total Hip Replacement Implants (cemented, cementless, hybrid): Complete replacement of both femoral head and acetabulum.
  • Partial Hip Replacement Implants (hemiarthroplasty): Typically replaces only the femoral head, commonly for femoral neck fractures.
  • Hip Resurfacing Implants: Involves capping the femoral head and lining the acetabulum, preserving more bone.
  • Revision Hip Replacement Implants: Designed for replacing failed primary or previous revision implants.
• Material: This segment focuses on the bearing surfaces of the implant, critical for durability and wear.
  • Metal-on-Polyethylene (MoP): Traditional and widely used, offering a balance of cost and performance.
  • Ceramic-on-Polyethylene (CoP): Provides excellent wear resistance with reduced debris.
  • Ceramic-on-Ceramic (CoC): Known for extremely low wear rates and high biocompatibility.
  • Metal-on-Metal (MoM): Historically used, but facing scrutiny due to potential ion release, leading to reduced use.
• End-User: This segment differentiates the primary healthcare settings where procedures are performed.
  • Hospitals: The traditional and dominant setting for complex hip replacement surgeries.
  • Ambulatory Surgical Centers (ASCs): Growing segment for elective, less complex procedures due to cost-efficiency.
  • Orthopedic Clinics: Primary sites for pre-operative consultations, post-operative follow-ups, and non-surgical management.
• Procedure: This segment classifies the market based on the specific surgical intervention performed.
  • Total Hip Arthroplasty (THA): The most common and comprehensive hip replacement procedure.
  • Partial Hip Arthroplasty (PHA): Primarily for femoral head replacement, often due to fractures.
  • Revision Hip Arthroplasty: A complex procedure to replace failed hip implants.

Value Chain Analysis For Hip Replacement Market

The value chain within the Hip Replacement Market is remarkably complex and multifaceted, encompassing a series of highly specialized stages that collaboratively contribute to the successful development, production, delivery, and post-surgical support of hip replacement products and services. The upstream segment of this value chain is fundamentally centered around the sourcing and meticulous supply of highly specialized raw materials. These critical inputs include medical-grade alloys such as titanium and cobalt-chromium, advanced bio-ceramics, and ultra-high molecular weight polyethylene (UHMWPE). These raw materials undergo rigorous quality control and specialized processing by dedicated component manufacturers, who precisely mold and machine them into the intricate shapes and exact dimensions required for each implant component. This initial phase demands substantial investment in advanced material science research, sophisticated manufacturing technologies, and stringent quality assurance protocols to ensure the biocompatibility, mechanical strength, and long-term durability essential for meeting demanding medical device standards and regulatory compliance.

Transitioning downstream, the precisely fabricated implant components are subsequently assembled, meticulously sterilized, and securely packaged by leading medical device manufacturers. These manufacturers then deploy sophisticated distribution strategies, typically employing a hybrid approach that combines direct sales forces with indirect distribution channels. Direct sales channels are often utilized by larger, established manufacturers who cultivate direct relationships with major hospital networks, national and regional purchasing organizations, and high-volume academic surgical centers. This direct engagement model allows for personalized service, comprehensive technical support for surgeons and staff, and extensive educational programs on new product features and surgical techniques. Such direct interactions are instrumental in fostering strong brand loyalty, facilitating the rapid adoption of innovative products, and gathering invaluable direct feedback from end-users, thereby streamlining the feedback loop for product improvement.

Conversely, indirect distribution channels involve strategic collaborations with a network of third-party distributors, wholesalers, and specialized medical supply companies. These partners possess extensive local and regional networks, enabling manufacturers to efficiently reach a broader array of smaller clinics, independent hospitals, and underserved geographical markets without the substantial overhead associated with establishing a fully integrated direct sales and logistics infrastructure. These distributors are responsible for managing complex logistics, maintaining optimal inventory levels, and often providing localized sales and technical support, acting as crucial intermediaries. The ultimate end-users of these advanced products are the highly skilled orthopedic surgeons who perform the intricate procedures, the hospitals and ambulatory surgical centers where these life-changing surgeries are conducted, and, most importantly, the patients who ultimately receive the implants. The value chain extends further to include essential post-surgical care, rehabilitation services, and ongoing patient monitoring, which form the crucial final links, ensuring optimal patient recovery, sustained implant longevity, and comprehensive support, thereby completing the holistic cycle of value delivery in the Hip Replacement Market.

Hip Replacement Market Potential Customers

The primary cohort of potential customers within the Hip Replacement Market comprises individuals who are experiencing profound and debilitating hip pain, severely impaired mobility, and a significant reduction in their overall quality of life due to various underlying hip joint pathologies. These end-users typically suffer from advanced stages of severe osteoarthritis, the chronic inflammatory effects of rheumatoid arthritis, devastating bone necrosis caused by avascular necrosis, the residual damage from post-traumatic arthritis, or acute, complex hip fractures that have proven refractory to conservative, non-surgical treatments. The demographic profile of these patients predominantly includes an aging global population, as degenerative joint conditions are far more prevalent in older adults. However, a notable segment also includes younger patients who may require surgical intervention due to severe trauma, congenital abnormalities, or specific medical conditions. All these patients share a common objective: seeking definitive and effective solutions to comprehensively alleviate their chronic pain and restore normal, functional hip joint mechanics.

Beyond the individual patient, the immediate institutional purchasers and key influencers of hip replacement products are a diverse array of healthcare entities. Hospitals, particularly those boasting robust orthopedic departments and specialized surgical capabilities, represent the largest and most significant segment of institutional buyers. This is attributed to the inherent complexity of hip replacement surgery, which necessitates advanced operating room facilities, sophisticated diagnostic imaging, comprehensive post-operative care units, and experienced multidisciplinary teams. Concurrently, ambulatory surgical centers (ASCs) are rapidly emerging as increasingly important purchasers. This trend is driven by a pronounced shift of less complex, elective hip replacement procedures towards outpatient settings, primarily motivated by greater cost-efficiency, reduced hospital stay durations, and patient preferences for a more streamlined surgical experience. Furthermore, specialized orthopedic clinics play a crucial role as vital referral sources, providing essential pre-operative evaluations, conservative management options, and critical long-term post-operative follow-up care for patients.

Moreover, orthopedic surgeons themselves are undeniably pivotal stakeholders and primary decision-makers who exert profound influence over the selection of specific implants. Their choices are meticulously informed by a complex interplay of individual patient needs, their extensive surgical expertise, the latest clinical evidence, and their practical experience with different implant systems. Therefore, their preferences for particular brands, material combinations, or implant designs significantly impact market demand and product adoption. Indirectly, health insurance providers, government healthcare programs, and national health systems also serve as critical customers. Their coverage policies, reimbursement rates, and value-based care initiatives profoundly affect patient access to, and the overall affordability and uptake of, hip replacement procedures. These multifaceted and interconnected groups collectively constitute the extensive and influential customer base that drives the dynamics of the Hip Replacement Market.

Hip Replacement Market Key Technology Landscape

The Hip Replacement Market is dynamically shaped by a constantly evolving and highly innovative technology landscape, with intensive research and development efforts strategically focused on profoundly enhancing surgical precision, substantially improving implant longevity, and significantly optimizing the entire patient recovery trajectory. A particularly transformative advancement is the accelerating and widespread adoption of robotic-assisted surgery systems. These sophisticated platforms empower orthopedic surgeons with unparalleled levels of dexterity, superior intra-operative visualization, and exceptional accuracy during the intricate process of implant placement. These advanced systems, frequently integrated with cutting-edge pre-operative imaging and detailed planning software, facilitate the creation of highly customized surgical approaches meticulously tailored to the unique anatomy of each individual patient. This technological synergy dramatically reduces the potential margin for human error, leading to far more consistent and predictable outcomes in critical aspects such as implant alignment, limb length restoration, and offset reconstruction, thus representing a profound paradigm shift towards greater control, standardization, and reproducibility in modern hip arthroplasty procedures, ultimately benefiting patient safety and functional recovery.

Another pivotal and rapidly advancing domain within the technological landscape resides in advanced material sciences and innovative manufacturing processes. Manufacturers are relentlessly pursuing research into and the development of novel biomaterials engineered to offer superior wear resistance, enhanced biocompatibility, and optimized mechanical properties that closely mimic natural bone. This includes groundbreaking innovations in highly cross-linked polyethylene for articulating bearing surfaces, which significantly minimizes wear debris, advanced ceramic composites that offer exceptional hardness and negligible wear, and sophisticated surface coatings for metallic implants designed to actively promote rapid bone ingrowth and durably reduce the long-term risk of aseptic loosening. Furthermore, the revolutionary capabilities of 3D printing and additive manufacturing technologies are increasingly being harnessed to produce fully customized, patient-specific implants. These bespoke designs precisely match unique anatomical variations, offering the potential for superior fit, optimized biomechanical function, and enhanced long-term stability, particularly in complex primary cases or challenging revision surgeries. These cutting-edge material and manufacturing innovations directly address critical challenges such as extended implant longevity, reduced revision rates, and improved functional outcomes.

Moreover, the Hip Replacement Market is witnessing a progressive and impactful integration of digital health solutions and artificial intelligence (AI) across various stages of the patient care pathway. Advanced computer-assisted navigation systems provide surgeons with real-time, dynamic feedback during surgery, guiding implant positioning with unprecedented accuracy and minimizing variability. AI-powered diagnostic tools and sophisticated predictive analytics are being developed to assist comprehensively in patient selection, meticulous risk assessment for potential complications, and the creation of highly personalized rehabilitation planning. These AI applications leverage vast datasets of clinical outcomes and patient characteristics to identify optimal treatment strategies and tailored post-operative care protocols. Additionally, smart remote patient monitoring devices, seamlessly integrated with AI capabilities, allow for continuous tracking of crucial recovery metrics, early detection of subtle changes indicative of potential complications, and immediate alerts to healthcare providers, facilitating timely interventions. These integrated digital technologies collectively not only optimize the surgical procedure itself but also profoundly enhance the entire patient journey, from pre-operative assessment through comprehensive post-operative recovery, thereby contributing significantly to superior overall patient satisfaction and consistently improved clinical outcomes in the rapidly evolving Hip Replacement Market.

Regional Highlights

• North America: This region maintains its dominant position within the Hip Replacement Market, underpinned by an exceptionally well-developed and robust healthcare infrastructure, consistently high levels of healthcare expenditure, and a leading adoption rate of cutting-edge medical technologies. The substantial presence of a large and progressively aging population, coupled with a high prevalence of debilitating musculoskeletal conditions such as osteoarthritis, fuels a persistent demand for hip arthroplasty. The region also benefits significantly from the concentration of major global market players and sustained, substantial investments in orthopedic research and development, further solidifying its leading role in technological innovation and market penetration.
• Europe: The European market demonstrates a trajectory of steady and reliable growth, characterized by strong governmental support for public healthcare systems, a proactive approach towards increasing patient awareness of advanced orthopedic treatment options, and a continuously growing geriatric population across its member states. Key contributing countries like Germany, the United Kingdom, and France are at the forefront, balancing the imperatives of technological innovation with a strong emphasis on achieving cost-effectiveness and value-based outcomes in healthcare service delivery. The regulatory landscape, while stringent, also promotes high standards of product quality and safety, contributing to patient confidence.
• Asia Pacific (APAC): Positioned as the fastest-growing regional market, APAC is experiencing vigorous expansion driven by a confluence of factors including rapidly improving healthcare infrastructure, a notable rise in disposable incomes, the burgeoning trend of medical tourism, and, critically, an immense and rapidly aging population base. Emerging economies such as China and India present extraordinarily significant opportunities due to their vast patient pools, increasing access to advanced medical care, and a growing willingness to adopt modern surgical techniques. The region's increasing investment in healthcare facilities and medical training further accelerates market development.
• Latin America: This region exhibits promising growth potential within the Hip Replacement Market, primarily fueled by increasing governmental and private healthcare investments, the expansion of a growing middle class with enhanced access to medical services, and rising awareness about available orthopedic surgical solutions. Countries like Brazil and Mexico are leading the market in this region, showcasing significant growth. However, persistent challenges related to equitable healthcare access, varying levels of economic stability, and fragmented healthcare systems continue to exist across certain areas, requiring nuanced market engagement strategies.
• Middle East and Africa (MEA): The MEA market is currently in a developing phase, yet it is showing notable momentum. Growth is primarily driven by substantial improvements in healthcare facilities, an increasing prevalence of chronic diseases across the population, and a concentrated focus on developing medical tourism initiatives in specific, well-resourced nations. However, the region faces considerable disparities in terms of healthcare access, economic development, and political stability, which collectively impact the overall market penetration and consistent adoption of advanced hip replacement technologies. Investment in infrastructure and specialized medical training remains a critical factor for sustained growth.

Top Key Players

• DePuy Synthes (Johnson & Johnson)
• Zimmer Biomet
• Stryker Corporation
• Smith & Nephew
• MicroPort Scientific Corporation
• B. Braun Melsungen AG
• Waldemar Link GmbH & Co. KG
• Limacorporate S.p.A.
• Corin Group
• Exactech Inc.
• ConforMIS
• DJO Global
• Medacta International
• OmniLife Science Inc.
• Meril Life Sciences Pvt. Ltd.
• Arthrex
• Aesculap Implants Systems
• Amplitude Surgical
• Auxein Medical
• OsteoRemedies LLC
• Peter Brehm GmbH
• Elite Surgical
• Adler Ortho S.p.A.
• Kyocera Medical Corporation

Frequently Asked Questions